Atorvastatin Calcium
Product Images NDC 60760-829

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 60760-829). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

829-30 (Atorvastatin 829 30)

FDA Label Image

Structure (Image 01)

FDA Label Image

Figure1 (Image 02)

FDA Label Image

Figure 2 (Image 03)

Figure 2 (Image 03)
The text presents data on cumulative hazard percentages of placebo and atorvastatin. The hazard ratio (HR) for atorvastatin is shown to be significantly lower than placebo over four years of follow-up. There is also a graph depicting time to first primary endpoint for both groups over four years.*
FDA Label Image

Figure 3 (Image 04)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.